四川医学2012，Vol.33Issue(2)：219-220,2.
吉西他滨联合奥沙利铂治疗晚期复发转移卵巢癌的临床观察
The clinical observation of Gemcitabine and oxaliplatin in relapse and metastasis ovarian cancer
任素蓉 1王晋 1张羽 1周筱秋 1杜小波1
作者信息
- 1. 绵阳市中心医院肿瘤科,四川绵阳621000
- 折叠
摘要
Abstract
Objective To research the effectiveness and adverse reaction of gemcitabine and oxaliplatin in relapse and metastasis ovarian cancer. Methods A total of 21 patients in the group were trated with gemcitabine and t oxaliplatin, after two cycle, they rpeated imaging、CA125 and researched effectiveness and adverse reaction. Results The total cure rates of these drugs was 38. 1% , nausea and vomiting incidence was 17 patients (80. 9% ) , neurotoxicity and cacesthesia was 13 patients (61. 9% ), leucocyte decline was 15 patients (71. 4% ) , blood cell decline was 13 patients (61. 9% ) ,red blood cell decline was 9 patients (42. 9% ). Conclusion Gemcitabine and oxaliplatin treated relapse and metastasis ovarian cancer had good effectiveness and low toxicity.the tolerance was good and quality of life was improved.关键词
复发卵巢肿瘤/吉西他滨/奥沙利铂/联合化疗Key words
relapse and metastasis ovarian cancer/egemcitabine/oxaliplatin分类
医药卫生引用本文复制引用
任素蓉,王晋,张羽,周筱秋,杜小波..吉西他滨联合奥沙利铂治疗晚期复发转移卵巢癌的临床观察[J].四川医学,2012,33(2):219-220,2.
